What Is Pharmacological Extinction?

The Short Answer

Pharmacological extinction is the process by which a learned behavior — in this case, drinking — is gradually weakened when the expected reward is repeatedly blocked by medication. It is the scientific foundation of the Sinclair Method.

How Learning and Reward Work

The brain learns through reward. When a behavior produces a pleasurable outcome, the brain strengthens the neural pathways associated with that behavior — making it more likely to be repeated. This is how habits form, and it is also how alcohol dependence develops.

Alcohol triggers the release of endorphins, which bind to opioid receptors in the brain's reward system. Over time, the brain learns that drinking produces reward — and this association becomes deeply reinforced. Cravings, compulsive drinking, and loss of control are all downstream effects of this learned reward association.

How Naltrexone Interrupts the Reward Signal

Naltrexone is an opioid receptor antagonist. It blocks the opioid receptors that mediate alcohol's rewarding effects. When you drink while naltrexone is active, the endorphins released by alcohol cannot bind to their receptors — and the brain does not receive the expected reward signal.

Why Extinction Requires Drinking

This is the counterintuitive insight at the heart of the Sinclair Method: extinction requires the behavior to occur without the reward. If you simply stop drinking, the learned association is not extinguished — it is suppressed. Suppressed associations can return when circumstances change.

By continuing to drink while naltrexone is active, the brain repeatedly experiences drinking without the expected reward. Over time, the association is weakened — not suppressed, but actually unlearned.

The Evidence

Pharmacological extinction in the context of alcohol use disorder was extensively studied by Dr. J.D. Sinclair and colleagues. The COMBINE study (2006) and multiple other trials have demonstrated that naltrexone reduces alcohol consumption and craving. The specific mechanism of extinction has been validated in both animal models and human clinical trials.